Highbridge Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Highbridge Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-123,299	Closed	-$6.45M	–	2052
2017 Q3	$6.45M	Buy	123,299 +4,938	+4%	+$275K	0.1%	245
2017 Q2	$6.92M	Buy	118,361 +103,852	+716%	+$5.4M	0.1%	246
2017 Q1	$665K	Sell	14,509 -6,141	-30%	-$306K	0.01%	780
2016 Q4	$1.09M	Sell	20,650 -37,835	-65%	-$1.83M	0.02%	522
2016 Q3	$2.61M	Sell	58,485 -117,695	-67%	-$5.1M	0.04%	389
2016 Q2	$6.72M	Sell	176,180 -25,802	-13%	-$1.13M	0.11%	212
2016 Q1	$8.32M	Buy	201,982 +84,585	+72%	+$3.49M	0.14%	185
2015 Q4	$5.7M	Sell	117,397 -93,874	-44%	-$4.18M	0.09%	255
2015 Q3	$8.45M	Buy	211,271 +110,935	+111%	+$4.85M	0.13%	205
2015 Q2	$4.03M	Buy	+100,336	New	+$3.46M	0.05%	354

Other funds holding SYNH

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Highbridge Capital Management's SYNH Position: Q4 2017 in Review

Highbridge Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2017, closing a stake of 123,299 shares — an estimated $6.45M sold.

Highbridge Capital Management first reported a position in SYNH in Q2 2015 and held it in 10 quarters. The position peaked at $8.45M in Q3 2015. 194 funds tracked by Wall St. Rank hold SYNH as of Q4 2017.

Highbridge Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2017 after selling out during the quarter.
Highbridge Capital Management sold 123,299 Syneos Health, Inc. Class A Common Stock shares in Q4 2017, an estimated $6.45M.
Highbridge Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 10 quarters.
Highbridge Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $8.45M in Q3 2015.
194 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2017.

Based on Highbridge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.